Long Term Cancer Survivors: Research Initiatives

The summary for the Long Term Cancer Survivors: Research Initiatives grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Long Term Cancer Survivors: Research Initiatives: The Long Term Cancer Survivors RFA re-issuance is a major initiative of the National Cancer Institute's FY 2004 Extraordinary Opportunity in Cancer Survivorship, and reflects the NCI's recognition of the critical importance and need for research that addresses the impact of cancer and its treatment on individuals living years beyond a cancer diagnosis. The population of long- term cancer survivors continues to grow: 62% of adult and 77% of pediatric cancer survivors survive beyond 5 yrs, and cancer can be for most a chronic disease. However, limited research has addressed outcomes of cancer and its treatment among long-term cancer survivors (those who are 5 years or more beyond cancer diagnosis). The request for re-issuance of this RFA is a clear signal to the research community regarding the critical need for more information about long-term cancer survivorship, especially among cancer survivors diagnosed as adults, and is intended to catalyze efforts to address the many unanswered questions in this challenging spectrum of the cancer control continuum. To be effective, applications are expected to cover the full range of domains affected by long-term survival from cancer (physiologic, psychologic, social, behavioral, economic) and emphasize understudied areas and gaps in current research. It is expected that interdisciplinary efforts will result in new and/or improved syntheses, theories, methods, and interventions. The purpose of this RFA re-issuance is to build upon the established research base and to provide a critical additional stimulus to the research community to undertake studies on cancer survivors who are 5 years or more post- diagnosis, focusing especially on research areas that remain understudied. It is critical that we expand and accelerate our potential to address the impact of long-term survival in particular with respect to: a) specific survivor groups: such as those treated for previously understudied cancer sites (e.g. colorectal, gynecologic, hematologic, head and neck), and those belonging to underserved populations (elderly, rural, low education/income, diverse racial and ethnic groups); and b) questions addressing specific gaps in our knowledge: such as the incidence of and risk factors for late and long-term (chronic or persistent) effects of cancer and its treatment, the role of socio-cultural and behavioral factors in modulating treatment outcomes, the impact of survivorship on health care utilization, the role of co-morbidity in outcomes, appropriate follow up care and surveillance for survivors, and the effect on families of living with a cancer history in a loved one. Results from the original RFA demonstrate that: (1) there are long latencies for potentially life-threatening late effects (e.g., heart failure secondary to the cardiotoxic effects of cancer treatment) emphasizing the need for extended follow up; (2) many disease and treatment related toxicities (e.g., fatigue, sexual dysfunction, cognitive impairment, neuropathies) can be persistent, worsen over time, and carry significant potential to adversely affect the health and well being of survivors; (3) the adverse sequelae of cancer and its treatment contribute to the ongoing burden of illness, costs, and decreased length/quality of survival; and (4) early identification of, and interventions among, those at increased risk for problems hold the promise of reducing adverse outcomes.
Federal Grant Title: Long Term Cancer Survivors: Research Initiatives
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-04-003
Type of Funding: Grant
CFDA Numbers: 93.399
CFDA Descriptions: Cancer Control
Current Application Deadline: No deadline provided
Original Application Deadline: Jun 16, 2003
Posted Date: Apr 16, 2003
Creation Date: Jul 16, 2003
Archive Date: Jul 16, 2003
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster OERWebmaster@od.nih.gov NIH OER Webmaster
Similar Government Grants
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinar...
Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinica...
Exploratory Grants for Behavioral Research in Cancer Control
Decision Making in Cancer: Single-Event Decisions
Small Grants for Behavioral Research in Cancer Control (R03)
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2019 FederalGrants.com